clifto wrote:
> SMS ???? ? wrote:
>> There are some good case studies of pricing in the Harvard Business
>> Review. The Tagamet versus Zantac is a classic.
>
> Is that on line somewhere? I've always had a suspicion that Tagamet
> was the start of the outrageous pricing of drugs we see today. I
> remember it was $30 a month as opposed to a typically expensive
> prescription of $12 or thereabouts. I remember also that they
> promised the price would drop like a rock when R&D was paid off, but
> the price did nothing but go up, quintupling just before a generic
> became available.
>
Pharmaceuticals is not a good example to use in this debate. The market
forces of the drug industry are different than other consumer goods. Not to
say that he doesn't have an ax to grind or that a lot of what he has to say
is biased, but you should make a point of seeing Michael Moore's "Sicko".